InsidersTradesSigma
Total declarations
Companies
▲ Purchases (26 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
26
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+21.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Titterton Lewis H jr, Director. Director active across 2 companies, notably Anixa Biosciences Inc. In total, 39 disclosures have been recorded. Split: 26 buys · 0 sell. Total volume traded: €1.5m. Activity tracked since 14 July 2021. The latest transaction was filed on 20 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Titterton Lewis H jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
12,000 shares@ US$3.470.036% mcap2.9% of flowCommon StockSEC:0001493152-26-033949:0
Canonical exit: 18 Oct 2026 (T+90)
2,797 shares@ US$3.280.0077% mcap0.7% of flowCommon StockSEC:0001493152-26-033461:0
Canonical exit: 13 Oct 2026 (T+90)
2,836 sharesCommon StockSEC:0001493152-26-029030:0
Canonical exit: 14 Sept 2026 (T+90)
16,000 shares@ US$2.922.6% of flowCommon StockSEC:0001493152-25-027904:0
4,761,905 shares@ US$0.2175.5% of flowCommon StockSEC:0001437749-25-035628:0
Canonical exit: 16 Feb 2026 (T+90)
525,000 shares@ US$0.1828.9% of flowCommon StockSEC:0001437749-25-030658:0
10,000 shares@ US$3.082.2% of flowCommon StockSEC:0001641172-25-022000:0
Canonical exit: 29 Oct 2025 (T+90)
10,000 shares@ US$3.141.8% of flowCommon StockSEC:0001641172-25-019587:0
Canonical exit: 9 Oct 2025 (T+90)
275,000 sharesCommon stockSEC:0001437749-25-022356:0
1,699,844 shares@ US$0.1397.6% of flowCommon StockSEC:0001641172-25-009406:0
2,000 shares@ US$2.910.4% of flowCommon StockSEC:0001493152-25-003733:0
Canonical exit: 23 Apr 2025 (T+90)
2,000 shares@ US$3.010.4% of flowCommon StockSEC:0001493152-25-003330:0
Canonical exit: 22 Apr 2025 (T+90)
6,000 shares@ US$2.591.0% of flowCommon StockSEC:0001493152-25-003157:0
Canonical exit: 21 Apr 2025 (T+90)
10,000 shares@ US$2.571.6% of flowCommon StockSEC:0001493152-25-002717:0
Canonical exit: 17 Apr 2025 (T+90)
2,000,000 shares0Common StockSEC:0001437749-25-000657:0
16,000 shares@ US$2.5752.5% of flowCommon StockSEC:0001493152-24-042183:0
29,413 shares@ US$0.172.4% of flowCommon StockSEC:0001437749-24-030006:0
21,646 shares@ US$3.064.0% of flowCommon StockSEC:0001493152-24-029884:0
Canonical exit: 28 Oct 2024 (T+90)
796 shares@ US$2.810.1% of flowCommon StockSEC:0001493152-24-029354:0
Canonical exit: 23 Oct 2024 (T+90)
4,000 shares@ US$2.680.7% of flowCommon StockSEC:0001493152-24-024226:0
Canonical exit: 12 Sept 2024 (T+90)
405 shares@ US$2.700.1% of flowCommon StockSEC:0001493152-24-023802:0
Canonical exit: 11 Sept 2024 (T+90)
330 shares@ US$2.600.1% of flowCommon StockSEC:0001493152-24-023560:0
Canonical exit: 8 Sept 2024 (T+90)
10,738 shares@ US$2.521.6% of flowCommon StockSEC:0001493152-24-023295:0
Canonical exit: 5 Sept 2024 (T+90)
15,009 shares@ US$3.283.0% of flowCommon StockSEC:0001493152-24-014154:0
Canonical exit: 8 Jul 2024 (T+90)
16,000 shares@ US$2.5752.6% of flowCommon StockSEC:0001493152-23-036871:0
25 of 39 declarations
About Titterton Lewis H jr
Titterton Lewis H jr is Administrateur at Anixa Biosciences Inc and Parkervision INC. He has 37 filings in total, and across the recent filings available, buys amount to EUR 1466962 with no sells, from 2021-07-15 to 2026-06-17. The modal transaction nature is Acquisition.
